Final report of an RCT in 322 adults aged ≥75: double-dose mRNA-1273 boosters gave numerically higher 12-month antibody levels and neutralisation than BNT162b2; second-booster twofold antibody rise was 87.2% vs 78.5% (P=0.056); grade 2 reactions were more frequent.
RCTn = 322
Stemler et al. Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report